-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Sarepta Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q4 2016 to Q2 2024.
- Sarepta Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $601K, a 236% increase year-over-year.
- Sarepta Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $2.4M, a 237% increase year-over-year.
- Sarepta Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $1.56M, a 118% increase from 2022.
- Sarepta Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $714K, a 1.13% increase from 2021.
- Sarepta Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $706K, a 6.65% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)